NIH-funded research NIH-funded research

Targeted Sleep Apnea Treatment with Dronabinol Instead of a generic pill

Official title: Targeted Treatment of Obstructive Sleep Apnea with Dronabinol: Proof of Concept and Phase II Clinical Trial

Funded at Jesse Brown VA Medical Center · NIH-11294174 · Data updated 2026-11-12

A study in veterans tests whether the FDA-approved drug dronabinol can reduce sleep apnea severity and who is most likely to benefit.

More Obstructive Sleep Apnea research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJesse Brown VA Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startMarch 1, 2025
Project endFebruary 28, 2031
Funding year2026
NIH project number5I01CX002632-02
Project IDNIH-11294174 on NIH RePORTER

Who could benefit from this research

Could help

Veterans with moderate to severe obstructive sleep apnea who may or may not have tried standard therapies.

Less likely to help

Patients with contraindications to dronabinol or those unlikely to respond based on the prediction model may not benefit.

What this research studies

This project will build a model to predict who from a group of veterans with obstructive sleep apnea might respond to dronabinol, using sleep studies and clinical data. If the model performs well, a phase II randomized trial will enroll veterans who are predicted to respond to dronabinol to test its efficacy over twelve weeks. If the prediction model isn’t robust, the trial will proceed with all eligible veterans to see if dronabinol lowers the apnea severity index compared with placebo. Data from these steps will help plan a future larger trial and refine patient selection. Participants will be recruited at the Jesse Brown VA Medical Center, and safety and efficacy will be monitored throughout the study.

Why it matters

Potential benefit: If successful, dronabinol could become a medication option for reducing sleep apnea severity in veterans, potentially improving sleep quality and cardiovascular risk.

How similar studies have gone: Earlier work showed some individuals had meaningful reductions in apnea severity with dronabinol, supporting further study.

Where this research is happening

  • Jesse Brown VA Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Prasad, Bharati — Jesse Brown VA Medical Center
  • Study coordinator: Prasad, Bharati

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.